{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:54:39Z","timestamp":1793019279156,"version":"4.5.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/md.0b013e318289ff1e","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:28:49Z","timestamp":1361471329000},"page":"98-108","source":"Crossref","is-referenced-by-count":95,"title":["Persistent Staphylococcus aureus Bacteremia"],"prefix":"10.1097","volume":"92","author":[{"given":"Yong Pil","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Sueng","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Oh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hee","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210309","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/605555","article-title":"Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.","volume":"49","author":"Ammerlaan","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R2-5-20210309","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis"},{"key":"R3-5-20210309","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/592053","article-title":"Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease.","volume":"198","author":"Bubeck Wardenburg","year":"2008","journal-title":"J Infect Dis"},{"key":"R4-5-20210309","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JCM.01822-07","article-title":"Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.","volume":"46","author":"Campbell","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R5-5-20210309","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R6-5-20210309","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R7-5-20210309","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"R8-5-20210309","first-page":"1235","article-title":"What is community-associated methicillin-resistant Staphylococcus aureus J Infect Dis.","volume":"197","author":"David","year":"2008","journal-title":""},{"key":"R9-5-20210309","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/cid\/cir932","article-title":"Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters.","volume":"54","author":"Deresinski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-5-20210309","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1086\/503777","article-title":"Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus.","volume":"193","author":"Diep","year":"2006","journal-title":"J Infect Dis"},{"key":"R11-5-20210309","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","article-title":"Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.","volume":"38","author":"Enright","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R12-5-20210309","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/520088","article-title":"Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection.","volume":"196","author":"Fowler","year":"2007","journal-title":"J Infect Dis"},{"key":"R13-5-20210309","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia.","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"R14-5-20210309","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.","volume":"190","author":"Fowler","year":"2004","journal-title":"J Infect Dis"},{"key":"R15-5-20210309","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"R16-5-20210309","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988.","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"R17-5-20210309","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1086\/506568","article-title":"Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.","volume":"43","author":"Hageman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R18-5-20210309","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/archinte.167.17.1861","article-title":"Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.","volume":"167","author":"Hawkins","year":"2007","journal-title":"Arch Intern Med"},{"key":"R19-5-20210309","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"R20-5-20210309","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00422-06","article-title":"Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.","volume":"50","author":"Howden","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-5-20210309","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","article-title":"Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease.","volume":"70","author":"Jarraud","year":"2002","journal-title":"Infect Immun"},{"key":"R22-5-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.","volume":"162","author":"Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"R23-5-20210309","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.","volume":"38","author":"Khatib","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"R24-5-20210309","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/00365540802441711","article-title":"Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.","volume":"41","author":"Khatib","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R25-5-20210309","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jac\/dkr169","article-title":"Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"66","author":"Khatib","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R26-5-20210309","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/383036","article-title":"Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia.","volume":"38","author":"Khosrovaneh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R27-5-20210309","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/jac\/dkm309","article-title":"A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea.","volume":"60","author":"Kim","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R28-5-20210309","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R29-5-20210309","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/JCM.00905-08","article-title":"Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.","volume":"46","author":"Lalani","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R30-5-20210309","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R31-5-20210309","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1086\/657419","article-title":"Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.","volume":"202","author":"Li","year":"2010","journal-title":"J Infect Dis"},{"key":"R32-5-20210309","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/jac\/dkq188","article-title":"Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.","volume":"65","author":"Lin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R33-5-20210309","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R34-5-20210309","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-5-20210309","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-5-20210309","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia: I. Etiology and ecology.","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"R37-5-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R38-5-20210309","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections.","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R39-5-20210309","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R40-5-20210309","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.diagmicrobio.2010.02.026","article-title":"Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.","volume":"67","author":"Neuner","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R41-5-20210309","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9343(76)90715-4","article-title":"Staphylococcus aureus bacteremia. Current clinical patterns.","volume":"60","author":"Nolan","year":"1976","journal-title":"Am J Med"},{"key":"R42-5-20210309","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/AAC.46.7.2155-2161.2002","article-title":"Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.","volume":"46","author":"Oliveira","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-5-20210309","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we cant get there from here.","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R44-5-20210309","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"65","author":"Paul","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R45-5-20210309","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1128\/IAI.70.9.4987-4996.2002","article-title":"Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus.","volume":"70","author":"Peacock","year":"2002","journal-title":"Infect Immun"},{"key":"R46-5-20210309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R47-5-20210309","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.00918-10","article-title":"Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients.","volume":"55","author":"Schweizer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-5-20210309","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.01028-10","article-title":"Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.","volume":"55","author":"Seidl","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-5-20210309","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.CCM.0000239121.09533.09","article-title":"Healthcare-associated bloodstream infection: a distinct entity Insights from a large U.S. database.","volume":"34","author":"Shorr","year":"2006","journal-title":"Crit Care Med"},{"key":"R50-5-20210309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00365540510038488","article-title":"The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.","volume":"37","author":"Siegman-Igra","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"R51-5-20210309","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R52-5-20210309","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/313650","article-title":"Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.","volume":"30","author":"Soriano","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R53-5-20210309","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R54-5-20210309","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkr301","article-title":"Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"66","author":"Walraven","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R55-5-20210309","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R56-5-20210309","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R57-5-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.38834.421713.2F","article-title":"Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.","volume":"333","author":"Wyllie","year":"2006","journal-title":"BMJ"},{"key":"R58-5-20210309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/595738","article-title":"Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.","volume":"199","author":"Xiong","year":"2009","journal-title":"J Infect Dis"},{"key":"R59-5-20210309","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","article-title":"Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.","volume":"65","author":"Yoon","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e318289ff1e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:35Z","timestamp":1620963275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201303000-00005"}},"subtitle":["A Prospective Analysis of Risk Factors, Outcomes, and Microbiologic and Genotypic Characteristics of Isolates"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e318289ff1e","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}